{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:15:08Z","timestamp":1794532508083,"version":"4.9.1"},"reference-count":110,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Immune checkpoints maintain immune homeostasis, but their dysregulation can impair antitumor immunity and promote tumor immune evasion. Accumulating evidence indicates that metals and metalloids are important modulators of immune checkpoint signaling; however, their underlying mechanisms and broader implications for human health have not been systematically synthesized. In this review, we conducted a comprehensive search of PubMed, Web of Science, and Scopus through March 2026 to identify peer-reviewed studies examining metal- and metalloid-associated changes in immune checkpoint expression or function in human, animal, and experimental models. Current evidence suggests that metals and metalloids modulate immune checkpoints in a highly context-dependent manner, with the strongest support for effects on the PD-1\/PD-L1 axis, whereas evidence for other checkpoints remains limited. Mechanistically, these effects converge on remodeling of the tumor immune microenvironment, oxidative stress, hypoxia signaling, inflammatory signal transduction, and tumor suppressor and protein homeostasis pathways, thereby influencing T-cell exhaustion, tumor immune evasion, and responses to immune checkpoint inhibitors (ICIs). Emerging clinical evidence further suggests that trace-element status, particularly zinc- and copper-related measures, may have value as candidate biomarkers in immuno-oncology. However, most evidence remains preclinical, and direct human evidence linking metal- and metalloid-associated checkpoint dysregulation to systemic adverse health outcomes or clinically actionable interventions is still limited. Overall, this review connects exposure biology with cancer immunology and identifies metal- and metalloid-associated immune checkpoint modulation as a plausible contributor to altered tumor immunity and a priority for future translational and population-based research.<\/jats:p>","DOI":"10.3389\/fimmu.2026.1862118","type":"journal-article","created":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:37:14Z","timestamp":1780637834000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Modulation of the PD-1\/PD-L1 axis and tumor immunity by metals and metalloids: mechanistic insights and human health implications"],"prefix":"10.3389","volume":"17","author":[{"given":"Zhenyu","family":"Lu","sequence":"first","affiliation":[{"name":"Laboratory of Environmental Medicine and Developmental Toxicology, Shantou University Medical College","place":["Shantou, Guangdong, China"]},{"name":"Department of Digestive Surgery, The First Affiliated Hospital of Shantou University Medical College","place":["Shantou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangcan","family":"Chen","sequence":"additional","affiliation":[{"name":"Laboratory of Environmental Medicine and Developmental Toxicology, Shantou University Medical College","place":["Shantou, Guangdong, China"]},{"name":"Department of Digestive Surgery, The First Affiliated Hospital of Shantou University Medical College","place":["Shantou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingle","family":"Qiu","sequence":"additional","affiliation":[{"name":"Laboratory of Environmental Medicine and Developmental Toxicology, Shantou University Medical College","place":["Shantou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Huo","sequence":"additional","affiliation":[{"name":"Laboratory of Environmental Medicine and Developmental Toxicology, Guangdong Key Laboratory of Environmental Pollution and Health, School of Environment, Jinan University","place":["Guangzhou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xijin","family":"Xu","sequence":"additional","affiliation":[{"name":"Laboratory of Environmental Medicine and Developmental Toxicology, Shantou University Medical College","place":["Shantou, Guangdong, China"]},{"name":"Department of Cell Biology and Genetics, Shantou University Medical College","place":["Shantou, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1298571","article-title":"The role of immune checkpoints in antitumor response: A potential antitumor immunotherapy","volume":"14","author":"Mej\u00eda-Guarnizo","year":"2023","journal-title":"Front Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00561","article-title":"Pd-1 and pd-l1 checkpoint signaling inhibition for cancer immunotherapy: Mechanism, combinations, and clinical outcome","volume":"8","author":"Alsaab","year":"2017","journal-title":"Front Pharmacol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3390\/nu15010123","article-title":"Essential minerals and metabolic adaptation of immune cells","volume":"15","author":"Alghamdi","year":"2022","journal-title":"Nutrients"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/nu12072074","article-title":"Relevance of essential trace elements in nutrition and drinking water for human health and autoimmune disease risk","volume":"12","author":"Cannas","year":"2020","journal-title":"Nutrients"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6730305","article-title":"Environmental chemistry and ecotoxicology of hazardous heavy metals: Environmental persistence, toxicity, and bioaccumulation","volume":"2019","author":"Ali","year":"2019","journal-title":"J Chem"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.643972","article-title":"Toxic mechanisms of five heavy metals: Mercury, lead, chromium, cadmium, and arsenic","volume":"12","author":"Balali-Mood","year":"2021","journal-title":"Front Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116769","article-title":"Heavy metals, oxidative stress, and the role of ahr signaling","volume":"482","author":"Kou","year":"2024","journal-title":"Toxicol Appl Pharmacol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2018.06.054","article-title":"Antigen-presenting cell-intrinsic pd-1 neutralizes pd-l1 in cis to attenuate pd-1 signaling in t cells","volume":"24","author":"Zhao","year":"2018","journal-title":"Cell Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.semcancer.2022.08.004","article-title":"Immune cellular components and signaling pathways in the tumor microenvironment","volume":"86","author":"Yenyuwadee","year":"2022","journal-title":"Semin Cancer Biol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfae061","article-title":"Fine-tuning tumor- and allo-immunity: Advances in the use of immune checkpoint inhibitors in kidney transplant recipients","volume":"17","author":"Van Meerhaeghe","year":"2024","journal-title":"Clin Kidney J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1568664","article-title":"Tiragolumab and tigit: Pioneering the next era of cancer immunotherapy","volume":"16","author":"Ghasemi","year":"2025","journal-title":"Front Pharmacol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2023.116787","article-title":"Arsenic up-regulates pd-l1 and enhances lung tumorigenesis through activation of stat3 in alveolar epithelial type 2 cells","volume":"482","author":"Xu","year":"2024","journal-title":"Toxicol Appl Pharmacol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7150\/jca.47111","article-title":"Arsenic trioxide (ato) induced degradation of cyclin d1 sensitized pd-1\/pd-l1 checkpoint inhibitor in oral and esophageal squamous cell carcinoma","volume":"11","author":"Zhu","year":"2020","journal-title":"J Cancer"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14136","article-title":"Arsenic sulfide reverses cisplatin resistance in non-small cell lung cancer in vitro and in vivo through targeting pd-l1","volume":"12","author":"Tian","year":"2021","journal-title":"Thorac Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216827","article-title":"Hexavalent chromium exposure activates the non-canonical nuclear factor kappa b pathway to promote immune checkpoint protein programmed death-ligand 1 expression and lung carcinogenesis","volume":"589","author":"Wang","year":"2024","journal-title":"Cancer Lett"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046776","article-title":"Human langerhans cells control th cells via programmed death-ligand 1 in response to bacterial stimuli and nickel-induced contact allergy","volume":"7","author":"Hitzler","year":"2012","journal-title":"PloS One"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20131916","article-title":"Pd-l1 is a novel direct target of hif-1\u03b1, and its blockade under hypoxia enhanced mdsc-mediated t cell activation","volume":"211","author":"Noman","year":"2014","journal-title":"J Exp Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1208485","article-title":"Iron-mediated oxidative stress induces pd-l1 expression via activation of c-myc in lung adenocarcinoma","volume":"11","author":"Battaglia","year":"2023","journal-title":"Front Cell Dev Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-23-0739","article-title":"Iron boosts anti-tumor type 1 t-cell responses and anti-pd1 immunotherapy","volume":"12","author":"Porte","year":"2024","journal-title":"Cancer Immunol Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1186\/s12885-023-11620-9","article-title":"Impact of low serum iron on treatment outcome of pd-1 inhibitors in advanced gastric cancer","volume":"23","author":"Yang","year":"2023","journal-title":"BMC Cancer"},{"key":"B21","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41392-025-02192-0","article-title":"The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer","volume":"10","author":"Guo","year":"2025","journal-title":"Signal Transduct Tgt Ther"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.Can-20-0471","article-title":"Intratumoral copper modulates pd-l1 expression and influences tumor immune evasion","volume":"80","author":"Voli","year":"2020","journal-title":"Cancer Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.18632\/aging.204380","article-title":"Efficacy of zinc carnosine in the treatment of colorectal cancer and its potential in combination with immunotherapy in vivo","volume":"14","author":"Tang","year":"2022","journal-title":"Aging Albany NY"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1389387","article-title":"Zinc dampens antitumor immunity by promoting foxp3(+) regulatory t cells","volume":"15","author":"Narayan","year":"2024","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2021.07.013","article-title":"Selenium stimulates the antitumour immunity: Insights to future research","volume":"155","author":"Razaghi","year":"2021","journal-title":"Eur J Cancer"},{"key":"B26","doi-asserted-by":"publisher","first-page":"17303","DOI":"10.1038\/s41598-021-96244-4","article-title":"Defining drinking water metal contaminant mixture risk by coupling zebrafish behavioral analysis with citizen science","volume":"11","author":"Babich","year":"2021","journal-title":"Sci Rep"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0512-0","article-title":"Inhibitory receptors and ligands beyond pd-1, pd-l1 and ctla-4: Breakthroughs or backups","volume":"20","author":"Andrews","year":"2019","journal-title":"Nat Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.00207.2015","article-title":"Hypoxia: A key player in antitumor immune response. A review in the theme: Cellular responses to hypoxia","volume":"309","author":"Noman","year":"2015","journal-title":"Am J Physiol Cell Physiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2017.06.007","article-title":"De novo epigenetic programs inhibit pd-1 blockade-mediated t cell rejuvenation","volume":"170","author":"Ghoneim","year":"2017","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2217\/imt-2016-0111","article-title":"Epigenetic regulation of immune checkpoints: Another target for cancer immunotherapy","volume":"9","author":"Ali","year":"2017","journal-title":"Immunotherapy"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114673","article-title":"Potassium channels, tumorigenesis and targeted drugs","volume":"162","author":"Xia","year":"2023","journal-title":"Biomed Pharmacot"},{"key":"B32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jdermsci.2021.11.007","article-title":"N6-methyladenosine-modified long non-coding rna agap2-as1 promotes psoriasis pathogenesis via mir-424\u20135p\/akt3 axis","volume":"105","author":"Xian","year":"2022","journal-title":"J Dermatol Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24359","article-title":"Iron and the liver","volume":"2","author":"Corradini","year":"2004","journal-title":"Pediatr Endocrinol Rev"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1186659","article-title":"Copper metabolism and hepatocellular carcinoma: Current insights","volume":"13","author":"Zhou","year":"2023","journal-title":"Front Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/cai2.150","article-title":"Impact of metallic nanoparticles on gut microbiota modulation in colorectal cancer: A review","volume":"3","author":"Kumar","year":"2024","journal-title":"Cancer Innov"},{"key":"B36","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13073-021-00923-w","article-title":"Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer","volume":"13","author":"Hayase","year":"2021","journal-title":"Genome Med"},{"key":"B37","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41575-019-0209-8","article-title":"Gut microbiota in colorectal cancer: Mechanisms of action and clinical applications","volume":"16","author":"Wong","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.2217\/mmt-2016-0013","article-title":"Pd-l1 in melanoma: Facts and myths","volume":"3","author":"Mandal\u00e0","year":"2016","journal-title":"Melanoma Manag"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106971","article-title":"Recent advances of molecular mechanisms of regulating pd-l1 expression in melanoma","volume":"88","author":"Han","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114547","article-title":"Chronic viral infection alters pd-1 locus subnuclear localization in cytotoxic cd8(+) t cells","volume":"43","author":"Sacrist\u00e1n","year":"2024","journal-title":"Cell Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.621917","article-title":"Effectiveness and safety of targeted agents combined with chemoradiotherapy for the treatment of esophageal cancer: A network meta-analysis","volume":"11","author":"Liu","year":"2021","journal-title":"Front Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18390","article-title":"The roles of essential trace elements in t cell biology","volume":"28","author":"Lan","year":"2024","journal-title":"J Cell Mol Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.20945\/2359-4292-2025-0075","article-title":"The impact of thyroid disorders on the gut microbiome: Emerging mechanisms and clinical relevance","volume":"70","author":"Silva","year":"2025","journal-title":"Arch Endocrinol Metab"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0802664","article-title":"Tumor regulatory t cells potently abrogate antitumor immunity","volume":"182","author":"Liu","year":"2009","journal-title":"J Immunol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01479","article-title":"Iron induces anti-tumor activity in tumor-associated macrophages","volume":"8","author":"Costa da Silva","year":"2017","journal-title":"Front Immunol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.101891","article-title":"Immune cell - produced ros and their impact on tumor growth and metastasis","volume":"42","author":"Kennel","year":"2021","journal-title":"Redox Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s40201-020-00455-2","article-title":"Effects of lead and cadmium on the immune system and cancer progression","volume":"18","author":"Ebrahimi","year":"2020","journal-title":"J Environ Health Sci Eng"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3390\/biom11111575","article-title":"Cadmium-induced kidney injury: Oxidative damage as a unifying mechanism","volume":"11","author":"Yan","year":"2021","journal-title":"Biomolecules"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2010.06.003","article-title":"Impact of developmental lead exposure on splenic factors","volume":"247","author":"Kasten-Jolly","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.3c07047","article-title":"The toxicity of mercury and its chemical compounds: Molecular mechanisms and environmental and human health implications: A comprehensive review","volume":"9","author":"Wu","year":"2024","journal-title":"ACS Omega"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.108642","article-title":"The impact of genetic variation on metabolism of heavy metals: Genetic predisposition","volume":"113","author":"Joneidi","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph17249225","article-title":"Urinary mercury levels and predictors of exposure among a group of Italian children","volume":"17","author":"Astolfi","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2025.112939","article-title":"Sex differences in\u00a0the\u00a0association between heavy metal exposure and frailty in the U.S. adults: A cross-sectional analysis","volume":"212","author":"Liu","year":"2025","journal-title":"Exp Gerontol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2021.111558","article-title":"Sex-specific neurotoxic effects of heavy metal pollutants: Epidemiological, experimental evidence and candidate mechanisms","volume":"201","author":"Gade","year":"2021","journal-title":"Environ Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0326057","article-title":"Serum zinc as a biomarker to predict the efficacy of immune checkpoint inhibitors in cancers","volume":"20","author":"Wang","year":"2025","journal-title":"PloS One"},{"key":"B56","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s41523-021-00313-w","article-title":"Tetrathiomolybdate (Tm)-associated copper depletion influences collagen remodeling and immune response in the pre-metastatic niche of breast cancer","volume":"7","author":"Liu","year":"2021","journal-title":"NPJ Breast Cancer"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2009.11.010","article-title":"Anti-inflammatory effect of Sanshuibaihu decoction may be associated with nuclear factor-Kb and p38 mapk\u03b1 in collagen-induced arthritis in rat","volume":"127","author":"Yang","year":"2010","journal-title":"J Ethnopharmacol"},{"key":"B58","article-title":"Zinc: fact sheet for health professionals","year":"2026"},{"key":"B59","unstructured":"Phase I\/Ii study of Seleno-L methionine (Slm) in sequential combination with fixed doses and schedules of Axitinib and Pembrolizumab (Sap) in locally advanced and metastatic clear cell renal cell carcinoma (Ccrcc)\n          \n          \n          2022"},{"key":"B60","article-title":"Selenium: Fact Sheet for Health Professionals","year":"2025"},{"key":"B61","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"Pd-1 and its ligands in tolerance and\u00a0immunity","volume":"26","author":"Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1080\/2162402x.2017.1364828","article-title":"Pd-1 expression on tumor-specific T cells: Friend or foe\u00a0for\u00a0immunotherapy","volume":"7","author":"Simon","year":"2017","journal-title":"Oncoimmunology"},{"key":"B63","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1749-6632.2010.05919.x","article-title":"The role of the Pd-1 pathway in autoimmunity and peripheral tolerance","volume":"1217","author":"Fife","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"B64","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1208\/s12248-021-00574-0","article-title":"Cancer immunotherapy update: Fda-approved checkpoint inhibitors and companion diagnostics","volume":"23","author":"Twomey","year":"2021","journal-title":"AAPS J"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.2147\/dddt.S267433","article-title":"Research status and outlook of Pd-1\/Pd-L1 inhibitors for cancer therapy","volume":"14","author":"Ai","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.795547","article-title":"Immunotherapy in ovarian cancer: Thinking beyond Pd-1\/Pd-L1","volume":"11","author":"Chardin","year":"2021","journal-title":"Front Oncol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.833310","article-title":"Soluble immune checkpoints are dysregulated in Covid-19 and heavy alcohol users with Hiv infection","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.2147\/ott.S48443","article-title":"Pd-1 as an emerging therapeutic target in renal cell carcinoma: Current evidence","volume":"7","author":"Tykodi","year":"2014","journal-title":"Onco Targets Ther"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1129730","article-title":"Pneumocystis jirovecii pneumonia associated with immune checkpoint inhibitors: A systematic literature review of published case reports and disproportionality analysis based on the Faers database","volume":"14","author":"Xia","year":"2023","journal-title":"Front Pharmacol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s10020-021-00294-3","article-title":"Identification of prognostic alternative splicing events related to the immune microenvironment of hepatocellular carcinoma","volume":"27","author":"Yu","year":"2021","journal-title":"Mol Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/82_2010_114","article-title":"Lag-3 in cancer immunotherapy","volume":"344","author":"Goldberg","year":"2011","journal-title":"Curr Top Microbiol Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6000","article-title":"Lag-3 transcriptomic expression patterns across Malignancies: Implications for precision immunotherapeutics","volume":"12","author":"Adashek","year":"2023","journal-title":"Cancer Med"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.3390\/molecules29020454","article-title":"Anti-Pd-L1-based bispecific antibodies targeting co-inhibitory and co-stimulatory molecules for cancer immunotherapy","volume":"29","author":"Geng","year":"2024","journal-title":"Molecules"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1103627","article-title":"The Tigit\/Cd226 axis regulates human T cell function","volume":"188","author":"Lozano","year":"2012","journal-title":"J Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/mc.23275","article-title":"Effects of checkpoint kinase 1 inhibition by prexasertib on the tumor immune microenvironment of head and neck squamous cell carcinoma","volume":"60","author":"Chaudhary","year":"2021","journal-title":"Mol Carcinog"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14235757","article-title":"The dual blockade of the Tigit and Pd-1\/Pd-L1 pathway as a new hope for ovarian cancer patients","volume":"14","author":"Paw\u0142owska","year":"2022","journal-title":"Cancers Bsl"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03516-1","article-title":"Tim-3 as a promising target for cancer immunotherapy in a wide range of tumors","volume":"72","author":"Sauer","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.667478","article-title":"Peripheral injection of Tim-3 antibody attenuates Vsv encephalitis by enhancing Mhc-I presentation","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20100643","article-title":"Targeting Tim-3 and Pd-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity","volume":"207","author":"Sakuishi","year":"2010","journal-title":"J Exp Med"},{"key":"B80","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s43556-025-00267-6","article-title":"Tim-3 teams up with Pd-1 in cancer immunotherapy: Mechanisms and perspectives","volume":"6","author":"Yan","year":"2025","journal-title":"Mol BioMed"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00221.2022","article-title":"Thrombospondin-1, Cd47, and Sirp\u03b1 display cell-specific molecular signatures in human islets and pancreata","volume":"324","author":"Erdem","year":"2023","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03465-9","article-title":"The Tsp1-Cd47-Sirp\u03b1 interactome: An immune triangle for the checkpoint era","volume":"72","author":"Montero","year":"2023","journal-title":"Cancer Immunol Immunother"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1012806","article-title":"Immunovirotherapy: The role of antibody based therapeutics combination with oncolytic viruses","volume":"13","author":"Jafari","year":"2022","journal-title":"Front Immunol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-025-01130-y","article-title":"A phase 1b\/2 study of the anti-Cd47 antibody magrolimab with cetuximab in patients with colorectal cancer and other solid tumors","volume":"20","author":"Eng","year":"2025","journal-title":"Tgt Oncol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13045-022-01364-7","article-title":"Immune checkpoint of B7-H3 in cancer: From immunology to clinical immunotherapy","volume":"15","author":"Zhao","year":"2022","journal-title":"J Hematol Oncol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.3390\/cancers15123207","article-title":"Recent advances in the management of clear cell renal cell carcinoma: Novel biomarkers and targeted therapies","volume":"15","author":"Schiavoni","year":"2023","journal-title":"Cancers Bsl"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01751-9","article-title":"New frontiers in immune checkpoint B7-H3 (Cd276) research and drug development","volume":"22","author":"Getu","year":"2023","journal-title":"Mol Cancer"},{"key":"B88","doi-asserted-by":"publisher","first-page":"53","DOI":"10.36401\/jipo-23-18","article-title":"B7-H3 inhibitors in oncology clinical trials: A review","volume":"7","author":"Feustel","year":"2024","journal-title":"J Immunother Precis Oncol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s12943-019-1087-y","article-title":"Sting: A master regulator in the cancer-immunity cycle","volume":"18","author":"Zhu","year":"2019","journal-title":"Mol Cancer"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2022.102461","article-title":"Indoleamine 2,3-dioxygenase (Ido) inhibitors and cancer immunotherapy","volume":"110","author":"Fujiwara","year":"2022","journal-title":"Cancer Treat Rev"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.117412","article-title":"Ido1 inhibitors are synergistic with Cxcl10 agonists in inhibiting colon cancer growth","volume":"179","author":"Yang","year":"2024","journal-title":"BioMed Pharmacother"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1437207","article-title":"Distinct characteristics of Btla\/Hvem axis expression on Tregs and its impact on the expansion and attributes of Tregs in patients with active pulmonary tuberculosis","volume":"14","author":"Tang","year":"2024","journal-title":"Front Cell Infect Microbiol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ccc.2019.08.006","article-title":"Check point inhibitors and their role in immunosuppression in sepsis","volume":"36","author":"Wakeley","year":"2020","journal-title":"Crit Care Clin"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01983","article-title":"Hiv infection is associated with downregulation of Btla expression on Mycobacterium tuberculosis-specific Cd4 T cells in active tuberculosis disease","volume":"10","author":"Barham","year":"2019","journal-title":"Front Immunol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12943-023-01845-4","article-title":"Beyond the anti-Pd-1\/Pd-L1 era: Promising role of the Btla\/Hvem axis as a future target for cancer immunotherapy","volume":"22","author":"Sordo-Bahamonde","year":"2023","journal-title":"Mol Cancer"},{"key":"B96","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1186\/s12935-023-03116-0","article-title":"Vista and its ligands: The next generation of promising therapeutic targets in immunotherapy","volume":"23","author":"Shekari","year":"2023","journal-title":"Cancer Cell Int"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-024-01336-6","article-title":"Vista-mediated immune evasion in cancer","volume":"56","author":"Zhang","year":"2024","journal-title":"Exp Mol Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1038\/s41467-024-47256-x","article-title":"Vista checkpoint inhibition by Ph-selective antibody Sns-101 with optimized safety and pharmacokinetic profiles enhances Pd-1 response","volume":"15","author":"Thisted","year":"2024","journal-title":"Nat Commun"},{"key":"B99","doi-asserted-by":"publisher","first-page":"47","DOI":"10.14216\/kjco.24322","article-title":"Unlocking new frontiers: Novel immune targets for next-generation cancer immunotherapy","volume":"21","author":"Zaheer","year":"2025","journal-title":"Korean J Clin Oncol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0374-x","article-title":"Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy","volume":"25","author":"Wang","year":"2019","journal-title":"Nat Med"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1490505","article-title":"Siglec15 in blood system diseases: From bench to bedside","volume":"15","author":"Fan","year":"2024","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1038\/srep03072","article-title":"Cd200r signaling inhibits pro-angiogenic gene expression by macrophages and suppresses choroidal neovascularization","volume":"3","author":"Horie","year":"2013","journal-title":"Sci Rep"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.2174\/1381612820666140130202911","article-title":"Brain innate immunity in the regulation of neuroinflammation: Therapeutic strategies by modulating Cd200-Cd200r interaction involve the cannabinoid system","volume":"20","author":"Hernang\u00f3mez","year":"2014","journal-title":"Curr Pharm Des"},{"key":"B104","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1186\/s40425-019-0710-1","article-title":"Phase I study of samalizumab in chronic lymphocytic leukemia and multiple myeloma: Blockade of the immune checkpoint Cd200","volume":"7","author":"Mahadevan","year":"2019","journal-title":"J Immunother Cancer"},{"key":"B105","doi-asserted-by":"publisher","first-page":"96","DOI":"10.18632\/oncotarget.28354","article-title":"The immunoregulatory protein Cd200 as a potentially lucrative yet elusive target for cancer therapy","volume":"14","author":"Shao","year":"2023","journal-title":"Oncotarget"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2009.00783.x","article-title":"The Cd160, Btla, Light\/Hvem pathway: A bidirectional switch regulating T-cell activation","volume":"229","author":"Cai","year":"2009","journal-title":"Immunol Rev"},{"key":"B107","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1186\/s12864-023-09433-y","article-title":"Evaluation of circulating microrna profiles in blood as potential candidate biomarkers in a subacute ruminal acidosis cow model - a pilot study","volume":"24","author":"Ojo","year":"2023","journal-title":"BMC Genomics"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.18632\/aging.206053","article-title":"Pan-cancer analysis of immune checkpoint receptors and ligands in various cells in the tumor immune microenvironment","volume":"16","author":"Jiang","year":"2024","journal-title":"Aging Albany NY"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2020.100975","article-title":"Selenium nanoparticles regulate selenoprotein to boost cytokine-induced killer cell-based cancer immunotherapy","volume":"35","author":"Liu","year":"2020","journal-title":"Nano Today"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00407","article-title":"Methylseleninic acid sensitizes ovarian cancer cells to T-cell-mediated killing by decreasing PD-L1 and VEGF levels","volume":"8","author":"Nair","year":"2018","journal-title":"Front Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1862118\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:37:20Z","timestamp":1780637840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1862118\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":110,"alternative-id":["10.3389\/fimmu.2026.1862118"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1862118","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,5]]},"article-number":"1862118"}}